Amgen biopharmaceuticals news

Amgen said during an investor meeting that it will begin paying a quarterly

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE